Incidence of Body Dysmorphic Disorder (BDD) in a Population of Patients Undergoing Orthognathic Surgery
IBDOS
1 other identifier
observational
90
1 country
1
Brief Summary
Assessment of the incidence of Body dismorphic disorder in a population candidated to orthognathic surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2025
CompletedFirst Posted
Study publicly available on registry
March 17, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2030
March 17, 2025
January 1, 2025
4.7 years
January 21, 2025
March 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
primary outcomes
\- Prevalence of body image disturbance (BDD) among patients undergoing orthognathic surgery.
2 years
Interventions
2 self administered questionnaire for diagnosis of dismorphophobia will be administered
Eligibility Criteria
candidates to orthognathic surgery
You may qualify if:
- Patients who are candidates for orthognathic surgery
- Age: 18 to 50 years;
- Informed consent
You may not qualify if:
- \- Patients diagnosed with another psychiatric pathology
- Patients affected by syndromes involving the cervical-facial district
- Patients affected by clefts
- Patients affected by OSAS and candidates for orthognathic surgery for this indication
- Patients affected by connective tissue disorders (e.g. Ehler-Danlos, scleroderma, etc.)
- Patients candidates for orthognathic surgery due to facial trauma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione Policlinico Gemelli IRCSS
Rome, RM, 00168, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alessandro Moro, MD
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2025
First Posted
March 17, 2025
Study Start
May 1, 2025
Primary Completion (Estimated)
January 1, 2030
Study Completion (Estimated)
January 1, 2030
Last Updated
March 17, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share